Phase 1 Dyskinesia Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

Food-Effect, Single and Multiple Dose Pharmacokinetics, Safety and Tolerability Study of 4-MUST, 128 mg, Tablets in Healthy Volunteers

Biliary DyskinesiaChronic Cholecystitis

Valenta Pharm JSC45 enrolled1 locationNCT07594977

Recruiting

Phase 1

Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100 mg Tablets in Healthy Volunteers.

Gallstone DiseaseIrritable Bowel SyndromeGERD+2 more

Valenta Pharm JSC36 enrolled1 locationNCT07421011

Recruiting

Phase 1Phase 2

Safety and Efficacy of LPM3770164 Sustained-release Tablets in Patients With Tardive Dyskinesia

Tardive Dyskinesia (TD)

Luye Pharma Group Ltd.120 enrolled1 locationNCT06731868